117 related articles for article (PubMed ID: 24507924)
1. Inhibition of glutamate racemase by substrate-product analogues.
Pal M; Bearne SL
Bioorg Med Chem Lett; 2014 Mar; 24(5):1432-6. PubMed ID: 24507924
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of serine and proline racemases by substrate-product analogues.
Harty M; Nagar M; Atkinson L; Legay CM; Derksen DJ; Bearne SL
Bioorg Med Chem Lett; 2014 Jan; 24(1):390-3. PubMed ID: 24314397
[TBL] [Abstract][Full Text] [Related]
3. Substrate-induced conformational changes in Bacillus subtilis glutamate racemase and their implications for drug discovery.
Ruzheinikov SN; Taal MA; Sedelnikova SE; Baker PJ; Rice DW
Structure; 2005 Nov; 13(11):1707-13. PubMed ID: 16271894
[TBL] [Abstract][Full Text] [Related]
4. Changes in quaternary structure cause a kinetic asymmetry of glutamate racemase-catalyzed homocysteic acid racemization.
Mackie J; Kumar H; Bearne SL
FEBS Lett; 2018 Oct; 592(20):3399-3413. PubMed ID: 30194685
[TBL] [Abstract][Full Text] [Related]
5. Kinetic characterization and quaternary structure of glutamate racemase from the periodontal anaerobe Fusobacterium nucleatum.
Potrykus J; Flemming J; Bearne SL
Arch Biochem Biophys; 2009 Nov; 491(1-2):16-24. PubMed ID: 19772853
[TBL] [Abstract][Full Text] [Related]
6. How the substrate D-glutamate drives the catalytic action of Bacillus subtilis glutamate racemase.
Puig E; Mixcoha E; Garcia-Viloca M; González-Lafont A; Lluch JM
J Am Chem Soc; 2009 Mar; 131(10):3509-21. PubMed ID: 19227983
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for glutamate racemase inhibition.
Kim KH; Bong YJ; Park JK; Shin KJ; Hwang KY; Kim EE
J Mol Biol; 2007 Sep; 372(2):434-43. PubMed ID: 17658548
[TBL] [Abstract][Full Text] [Related]
8. Resistance mechanism to an uncompetitive inhibitor of a single-substrate, single-product enzyme: a study of Helicobacter pylori glutamate racemase.
Keating TA
Future Med Chem; 2013 Jul; 5(11):1203-14. PubMed ID: 23859203
[TBL] [Abstract][Full Text] [Related]
9. Determinants of catalytic power and ligand binding in glutamate racemase.
Spies MA; Reese JG; Dodd D; Pankow KL; Blanke SR; Baudry J
J Am Chem Soc; 2009 Apr; 131(14):5274-84. PubMed ID: 19309142
[TBL] [Abstract][Full Text] [Related]
10. Characterization of yrpC gene product of Bacillus subtilis IFO 3336 as glutamate racemase isozyme.
Ashiuchi M; Soda K; Misono H
Biosci Biotechnol Biochem; 1999 May; 63(5):792-8. PubMed ID: 10380621
[TBL] [Abstract][Full Text] [Related]
11. Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors.
Malapati P; Krishna VS; Nallangi R; Srilakshmi RR; Sriram D
Eur J Med Chem; 2018 Feb; 145():23-34. PubMed ID: 29310027
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of new antimicrobial agents on Bacillus spp. strains: docking affinity and in vitro inhibition of glutamate-racemase.
Tamay-Cach F; Correa-Basurto J; Villa-Tanaca L; Mancilla-Percino T; Juárez-Montiel M; Trujillo-Ferrara JG
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1026-33. PubMed ID: 22871135
[TBL] [Abstract][Full Text] [Related]
13. In silico optimization of a fragment-based hit yields biologically active, high-efficiency inhibitors for glutamate racemase.
Whalen KL; Chau AC; Spies MA
ChemMedChem; 2013 Oct; 8(10):1681-9. PubMed ID: 23929705
[TBL] [Abstract][Full Text] [Related]
14. Roles and regulation of the glutamate racemase isogenes, racE and yrpC, in Bacillus subtilis.
Kimura K; Tran LP; Itoh Y
Microbiology (Reading); 2004 Sep; 150(Pt 9):2911-2920. PubMed ID: 15347750
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the Catalytic Power of Glutamate Racemase by Investigating a Series of Covalent Inhibitors.
Vance NR; Witkin KR; Rooney PW; Li Y; Pope M; Spies MA
ChemMedChem; 2018 Dec; 13(23):2514-2521. PubMed ID: 30264520
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling and docking studies of glutamate racemase in Vibrio vulnificus CMCP6.
Vidya N; Vadivukkarasi B; Manivannan G; Anbarasu K
In Silico Biol; 2008; 8(5-6):471-83. PubMed ID: 19374132
[TBL] [Abstract][Full Text] [Related]
17. Competing Substrates for the Bifunctional Diaminopimelic Acid Epimerase/Glutamate Racemase Modulate Peptidoglycan Synthesis in Chlamydia trachomatis.
Singh R; Slade JA; Brockett M; Mendez D; Liechti GW; Maurelli AT
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33106295
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for an atypical active site of an L-aspartate/glutamate-specific racemase from Escherichia coli.
Ahn JW; Chang JH; Kim KJ
FEBS Lett; 2015 Dec; 589(24 Pt B):3842-7. PubMed ID: 26555188
[TBL] [Abstract][Full Text] [Related]
19. Exploitation of structural and regulatory diversity in glutamate racemases.
Lundqvist T; Fisher SL; Kern G; Folmer RH; Xue Y; Newton DT; Keating TA; Alm RA; de Jonge BL
Nature; 2007 Jun; 447(7146):817-22. PubMed ID: 17568739
[TBL] [Abstract][Full Text] [Related]
20. Isolation of peptide ligands that inhibit glutamate racemase activity from a random phage display library.
Kim WC; Rhee HI; Park BK; Suk KH; Cha SH
J Biomol Screen; 2000 Dec; 5(6):435-40. PubMed ID: 11598461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
